Immune dysregulation and autoimmunity in bipolar disorder: Synthesis of the evidence and its clinical application
The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Objective: Increasing evidence suggests that inflammation and immune dysregulation play an important role in the pathogenesis of bipolar disorder. Because the brain can be affected by various autoimmune processes, it is possible that some psychiatric disorders may have an autoimmune basis. Method: This article reviews the literature on peripheral and central immune dysregulation and autoimmunity in bipolar disorder. The mechanisms of the innate and adaptive immune systems in the pathophysiology of bipolar disorder are explored. The clinical features and pathogenesis of neuropsychiatric systemic lupus erythematosus, anti-NMDA encephalitis, and Hashimoto’s encephalopathy are summarized. Results: Neuroinflammation and peripheral immune dysregulation may play a role in the pathophysiology of bipolar disorder. This involves a complex interaction between immune cells of the central nervous system and periphery resulting in cellular damage through mechanisms involving excitotoxicity, oxidative stress, and mitochondrial dysfunction. Neuropsychiatric systemic lupus erythematosus, anti-NMDA encephalitis, and Hashimoto’s encephalopathy are important differentials for a psychiatrist to consider when suspecting autoimmune encephalopathy. Conclusions: The link between immune dysregulation, autoimmunity, and bipolar disorder may be closer than previously thought. Psychiatrists should be vigilant for autoimmunity in presentations of bipolar disorder due to its high morbidity and therapeutic implications. Advances in neuroimaging and biomarker identification related to immune dysregulation and neuroinflammation will contribute to our knowledge of the pathophysiology of bipolar disorder.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Common polygenic variation contributes to risk of schizophrenia and bipolar disorder
The International Schizophrenia Consortium (2009) · Nature · doi:10.1038/nature08185 · Cited by 4,821
Neurotrophins: Roles in Neuronal Development and Function
Huang, E. J., & Reichardt, L. F. (2001) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.24.1.677 · Cited by 4,394
Microglia-mediated neurotoxicity: uncovering the molecular mechanisms
Block, M. L., Zecca, L., & Hong, J.-S. (2007) · Nature Reviews Neuroscience · doi:10.1038/nrn2038 · Cited by 4,110 · cited 3×
“Two postulated signals are direct stimulation by endogenous proteins or environmental toxins and neuronal damage-released DAMPs recognizable by microglial TLR (Block et al., 2007; Ransohoff and Brown, 2012).”
BackgroundInflammation and Its Discontents: The Role of Cytokines in the Pathophysiology of Major Depression
Miller, A. H., Maletic, V., & Raison, C. L. (2009) · Biological Psychiatry · doi:10.1016/j.biopsych.2008.11.029 · Cited by 3,848 · cited 3×
“TNF-α has a direct toxic effect on oligodendroglia, potentially contributing to apoptosis and demyelination (Miller et al., 2009), and it is inversely related to the brain-derived neurotrophic factor concentration, which is known to be reduced in bipolar disorder (Brietzke and Kapczinski, 2008; Kapczinski et al.”
BackgroundInfluentialAnti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies
Dalmau, J., Gleichman, A. J., Hughes, E. G., Rossi, J. E., Peng, X., Lai, M., Dessain, S. K., Rosenfeld, M. R., Balice-Gordon, R., & Lynch, D. R. (2008) · The Lancet Neurology · doi:10.1016/s1474-4422(08)70224-2 · Cited by 3,488 · cited 1×
“The antibody in anti-NMDA encephalitis specifically recognizes the NR1 subunit of the NMDA receptor, which is present in all NMDA receptors (Dalmau et al., 2008).”
BackgroundPsychological stress and the human immune system: a meta-analytic study of 30 Years of inquiry
Segerstrom, S. C., & Miller, G. E. (2004) · Psychological Bulletin · doi:10.1037/0033-2909.130.4.601 · Cited by 3,334
Inflammatory Blockade Restores Adult Hippocampal Neurogenesis
Monje, M. L., Toda, H., & Palmer, T. D. (2003) · Science · doi:10.1126/science.1088417 · Cited by 2,426
Chronic stress, glucocorticoid receptor resistance, inflammation, and disease risk
Cohen, S., Janicki-Deverts, D., Doyle, W. J., Miller, G. E., Frank, E., Rabin, B. S., & Turner, R. B. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1118355109 · Cited by 1,419 · cited 1×
“In chronic stress, however, prolonged elevated cortisol release leads to downregulation of cortisol receptors on T lymphocytes resulting in unrestricted tissue damage and amplification of the immune response resulting in autoimmunity in susceptible individuals (Cohen et al., 2012).”
BackgroundBerk, M., Kapczinski, F., Andreazza, A. C., Dean, O. M., Giorlando, F., Maes, M., Yücel, M., Gama, C. S., Dodd, S., Dean, B., et al. (2011) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2010.10.001 · Cited by 1,178
Toll-like receptors in systemic autoimmune disease
Marshak-Rothstein, A. (2006) · Nature Reviews Immunology · doi:10.1038/nri1957 · Cited by 1,116 · cited 1×
“TLR on the surface of T and B cells are considered to play an important role in the initiation and progression of systemic autoimmune disease through recognition of exogenous and endogenous antigens (Marshak-Rothstein, 2006).”
BackgroundTyring, S., Gottlieb, A., Papp, K., Gordon, K., Leonardi, C., Wang, A., Lalla, D., Woolley, M., Jahreis, A., Zitnik, R., et al. (2006) · The Lancet · doi:10.1016/s0140-6736(05)67763-x · Cited by 1,069 · cited 2×
“Existing cytokine inhibitors (anti-TNF-α), such as etanercept, adalimumab, and infliximab, are used in the management of rheumatoid arthritis and psoriasis and have been shown to both relieve the symptoms of psoriasis and improve affective, somatic, and cognitive functions (Soczynska et al., 2009; Tyring et al., 2006)…”
BackgroundInnate immunity in the central nervous system
Ransohoff, R. M., & Brown, M. A. (2012) · Journal of Clinical Investigation · doi:10.1172/jci58644 · Cited by 1,034 · cited 11×
“TLR and NLR can recognize pathogen-associated molecular patterns (PAMPs) during infection or damage-associated molecular patterns (DAMPs) such as intracellular protein and non-protein products and nucleic acids during neuronal injury.”
BackgroundInfluentialKapur, S., Phillips, A. G., & Insel, T. R. (2012) · Molecular Psychiatry · doi:10.1038/mp.2012.105 · Cited by 980 · cited 1×
“This is in line with proposals by Kapur et al. (2012) for “stratified psychiatry”, which will improve clinical outcomes across conventional diagnostic boundaries.”
ResultOligodendrocytes: biology and pathology
Bradl, M., & Lassmann, H. (2010) · Acta Neuropathologica · doi:10.1007/s00401-009-0601-5 · Cited by 933 · cited 3×
“…directed against an epitope on the extracellular surface of oligodendrocytes can induce demyelination Australian & New Zealand Journal of Psychiatry, 47(12) either through activation of complement or through their recognition by Fc-receptors of activated macrophages (Bradl and Lassmann, 2010).”
BackgroundThe weight of leptin in immunity
Cava, A. L., & Matarese, G. (2004) · Nature Reviews Immunology · doi:10.1038/nri1350 · Cited by 927 · cited 1×
“Leptin is an adipocyte-derived cytokine that is of interest in the pathogenesis of bipolar disorder as it plays an important role in obesity and promotes Th1 cell differentiation modulating immune responses (La Cava and Matarese, 2004).”
BackgroundViviani, B., Bartesaghi, S., Gardoni, F., Vezzani, A., Behrens, M. M., Bartfai, T., Binaglia, M., Corsini, E., Di Luca, M., Galli, C. L., et al. (2003) · The Journal of Neuroscience · doi:10.1523/jneurosci.23-25-08692.2003 · Cited by 893
Neuroinflammation and psychiatric illness
Najjar, S., Pearlman, D. M., Alper, K., Najjar, A., & Devinsky, O. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-43 · Cited by 733
Oxidative stress markers in bipolar disorder: A meta-analysis
Andreazza, A. C., Kauer-Sant'Anna, M., Frey, B. N., Bond, D. J., Kapczinski, F., Young, L. T., & Yatham, L. N. (2008) · Journal of Affective Disorders · doi:10.1016/j.jad.2008.04.013 · Cited by 526
Rao, J. S., Harry, G. J., Rapoport, S. I., & Kim, H. W. (2010) · Molecular Psychiatry · doi:10.1038/mp.2009.47 · Cited by 432 · cited 1×
“Postmortem studies in bipolar disorder have shown the presence of excitotoxic markers and neuroinflammation in the frontal cortex with activation of the IL-1 receptor cascade (Rao et al., 2010).”
BackgroundPsychiatric Complications of Long-term Interferon Alfa Therapy
Renault, P. F. (1987) · Archives of Internal Medicine · doi:10.1001/archinte.1987.00370090055011 · Cited by 413 · cited 1×
“The strongest clinical evidence for the pathogenic role of cytokines comes from the effects of IFNα in the treatment of hepatitis C and cancer (Renault et al., 1987).”
BackgroundDantzer, R., Konsman, J.-P., Bluthé, R.-M., & Kelley, K. W. (2000) · Autonomic Neuroscience · doi:10.1016/s1566-0702(00)00220-4 · Cited by 400 · cited 3×
“Peripheral cytokines can enter the BBB through areas of the brain that lack the BBB, such as the circumventricular organs (Dantzer et al., 2000), and the vagus nerve acts as a connection between the peripheral immune system and the brain (Gidron et al., 2007).”
BackgroundMitochondrial dysfunction and pathology in bipolar disorder and schizophrenia
Clay, H. B., Daws, S., & Konradi, C. (2011) · International Journal of Developmental Neuroscience · doi:10.1016/j.ijdevneu.2010.08.007 · Cited by 399 · cited 1×
“Elevated levels of glutamate, markers of oxidative stress, and mitochondrial dysfunction are found in the brains of individuals with bipolar disorder (Andreazza et al., 2008; Clay et al., 2011; Gigante et al., 2012; Hashimoto et al., 2007).”
BackgroundDepression: an inflammatory illness?: Figure 1
Krishnadas, R., & Cavanagh, J. (2012) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp-2011-301779 · Cited by 392 · cited 2×
“A large body of evidence points to a role for inflammatory mediators and immune dysregulation in the pathogenesis of psychiatric disorders such as schizophrenia, depression, and Alzheimer’s disease (Fan et al., 2007; Krishnadas and Cavanagh, 2012; Moscavitch et al., 2009; Zotova et al., 2010).”
BackgroundImbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder
Kim, Y.-K., Jung, H.-G., Myint, A.-M., Kim, H., & Park, S.-H. (2007) · Journal of Affective Disorders · doi:10.1016/j.jad.2007.02.018 · Cited by 375
Cytokine activation of the HPA axis
DUNN, A. J. (2000) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.2000.tb05426.x · Cited by 352 · cited 1×
“Cytokines such as IL-6 and TNF-α activate the hypothalamic–pituitary–adrenal axis, increasing cortisol levels which can be neurotoxic and may be central to the pathogenesis of depressive symptoms and cognitive deficits (Daban et al., 2005; Dunn, 2000).”
BackgroundPadmos, R. C., Hillegers, M. H. J., Knijff, E. M., Vonk, R., Bouvy, A., Staal, F. J. T., de Ridder, D., Kupka, R. W., Nolen, W. A., & Drexhage, H. A. (2008) · Archives of General Psychiatry · doi:10.1001/archpsyc.65.4.395 · Cited by 336 · cited 2×
“The monocytes of a large proportion of bipolar patients and the offspring of bipolar parents show an inflammatory gene expression signature (Padmos et al., 2008) and are believed to arise from a shared environmental factor (Padmos et al.”
BackgroundMaes, M., Fišar, Z., Medina, M., Scapagnini, G., Nowak, G., & Berk, M. (2012) · Inflammopharmacology · doi:10.1007/s10787-011-0111-7 · Cited by 325
Liu, W., Tang, Y., & Feng, J. (2011) · Life Sciences · doi:10.1016/j.lfs.2011.05.011 · Cited by 303 · cited 2×
“Cross-talk between microglia and astrocytes has been implicated in several neurological conditions, but the details of this interaction are still unclear (Liu et al., 2011b).”
BackgroundCytokine profiles in bipolar affective disorder: focus on acutely ill patients.
O'Brien, S. M., Scully, P., Scott, L. V., & Dinan, T. G. (2006) · Journal of Affective Disorders · doi:10.1016/j.jad.2005.11.015 · Cited by 285
Vallés, S. L., Blanco, A. M., Pascual, M., & Guerri, C. (2004) · Brain Pathology · doi:10.1111/j.1750-3639.2004.tb00079.x · Cited by 271 · cited 1×
“The role of smoking cessation and addressing alcohol misuse should not be overlooked, as smoking is a direct contributory factor to the passage of cytokines through the BBB, and alcohol exerts pro-apoptotic effects on neuronal cells (Valles et al., 2004).”
BackgroundAutoimmune diseases, bipolar disorder, and non-affective psychosis
Eaton, W. W., Pedersen, M. G., Nielsen, P. R., & Mortensen, P. B. (2010) · Bipolar Disorders · doi:10.1111/j.1399-5618.2010.00853.x · Cited by 262 · cited 2×
“A large Danish cohort study showed that autoimmune processes precede the onset of bipolar disorder (Eaton et al., 2010).”
BackgroundCytokines in bipolar disorder: A systematic review and meta-analysis
Munkholm, K., Vinberg, M., & Vedel Kessing, L. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2012.06.010 · Cited by 256 · cited 1×
“The levels of sTNFR1 were also elevated in bipolar euthymic patients compared to healthy control subjects (Munkholm et al., 2013).”
BackgroundHypothalamic-pituitary-adrenal axis and bipolar disorder
Daban, C., Vieta, E., Mackin, P., & Young, A. H. (2005) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2005.01.005 · Cited by 245 · cited 1×
“Cytokines such as IL-6 and TNF-α activate the hypothalamic–pituitary–adrenal axis, increasing cortisol levels which can be neurotoxic and may be central to the pathogenesis of depressive symptoms and cognitive deficits (Daban et al., 2005; Dunn, 2000).”
BackgroundBasal Ganglia Hypermetabolism and Symptoms of Fatigue during Interferon-α Therapy
Capuron, L., Pagnoni, G., Demetrashvili, M. F., Lawson, D. H., Fornwalt, F. B., Woolwine, B., Berns, G. S., Nemeroff, C. B., & Miller, A. H. (2007) · Neuropsychopharmacology · doi:10.1038/sj.npp.1301362 · Cited by 229 · cited 2×
“IFN-α administration is associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia (Capuron et al., 2007) and anterior cingulated, which are associated with fatigue and cognitive effects respectively (Capuron et al., 2005).”
BackgroundZhu, C.-B., Carneiro, A. M., Dostmann, W. R., Hewlett, W. A., & Blakely, R. D. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410858200 · Cited by 228
Gigante, A. D., Bond, D. J., Lafer, B., Lam, R. W., Young, L. T., & Yatham, L. N. (2012) · Bipolar Disorders · doi:10.1111/j.1399-5618.2012.01033.x · Cited by 226 · cited 1×
“Elevated levels of glutamate, markers of oxidative stress, and mitochondrial dysfunction are found in the brains of individuals with bipolar disorder (Andreazza et al., 2008; Clay et al., 2011; Gigante et al., 2012; Hashimoto et al., 2007).”
BackgroundAnterior Cingulate Activation and Error Processing During Interferon-Alpha Treatment
Capuron, L., Pagnoni, G., Demetrashvili, M., Woolwine, B. J., Nemeroff, C. B., Berns, G. S., & Miller, A. H. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.03.033 · Cited by 222 · cited 2×
“IFN-α administration is associated with widespread bilateral increases in glucose metabolism in subcortical regions including the basal ganglia (Capuron et al., 2007) and anterior cingulated, which are associated with fatigue and cognitive effects respectively (Capuron et al., 2005).”
BackgroundMiller, A. H., Pariante, C. M., & Pearce, B. D. (1999) · Advances in Experimental Medicine and Biology · doi:10.1007/978-0-585-37970-8_7 · Cited by 203 · cited 1×
“Elevated cortisol levels reduce postsynaptic serotonin receptors, serotonin responsiveness, and brain-derived neurotrophic factor levels, thus affecting neurotransmitter regulation and neuroplasticity (Huang and Reichardt, 2001; Issa et al., 2010; Miller et al., 1999).”
BackgroundThe expression of proapoptosis genes is increased in bipolar disorder, but not in schizophrenia
Benes, F. M., Matzilevich, D., Burke, R. E., & Walsh, J. (2006) · Molecular Psychiatry · doi:10.1038/sj.mp.4001758 · Cited by 183 · cited 1×
“Individuals with bipolar disorder show a marked increase in the upregulation of pro-apoptotic genes along with a downregulation of antioxidant genes, inducing vulnerability to apoptosis and oxidative stress-induced damage (Benes et al., 2006).”
BackgroundZou, J., Wang, Y.-X., Dou, F.-F., Lü, H.-Z., Ma, Z.-W., Lu, P.-H., & Xu, X.-M. (2010) · Neurochemistry International · doi:10.1016/j.neuint.2009.12.021 · Cited by 181
TNF-α as a molecular target in bipolar disorder
Brietzke, E., & Kapczinski, F. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2008.01.006 · Cited by 163
The Emerging Link Between Autoimmune Disorders and Neuropsychiatric Disease
Kayser, M. S., & Dalmau, J. (2011) · Journal of Neuropsychiatry · doi:10.1176/appi.neuropsych.23.1.90 · Cited by 133 · cited 1×
“In contrast, the antineuronal antibodies in NPSLE recognize the NR2A and NR2B subunits of the NMDA receptor, which are highly concentrated in the hippocampus (Kayser and Dalmau, 2011).”
BackgroundCytokine production in bipolar affective disorder patients under lithium treatment
Boufidou, F., Nikolaou, C., Alevizos, B., Liappas, I. A., & Christodoulou, G. N. (2004) · Journal of Affective Disorders · doi:10.1016/j.jad.2004.01.007 · Cited by 130 · cited 2×
“Among psychotropics, lithium and clozapine (used in certain treatmentresistant illnesses) have immunosuppressive properties (Beurel et al., 2010; Boufidou et al., 2004; Knight et al., 2007; Maes et al., 2007) that possibly contribute to their superiority in treatment-resistant cases; however, their use in autoimmune e…”
BackgroundPsychiatric Manifestations of Paraneoplastic Disorders
Kayser, M. S., Kohler, C. G., & Dalmau, J. (2010) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2010.09101547 · Cited by 129 · cited 2×
“Over 200 patients with anti-NMDA encephalitis have been described, and 75% present initially to psychiatrists (Kayser et al., 2010).”
BackgroundB cells and autoantibodies: Complex roles in CNS injury
Ankeny, D. P., & Popovich, P. G. (2010) · Trends in Immunology · doi:10.1016/j.it.2010.06.006 · Cited by 116 · cited 1×
“Traumatic brain and spinal injuries are associated with antibody production, which is responsible for a range of somatic symptoms that cannot be explained purely by neurological injury (Ankeny and Popovich, 2010).”
BackgroundMaes, M., Ringel, K., Kubera, M., Berk, M., & Rybakowski, J. (2012) · Journal of Affective Disorders · doi:10.1016/j.jad.2011.11.016 · Cited by 116
Research works printed but not linked: 132
- 10.1093/bja/85.1.129 · DOI · Paper page
- 10.1176/appi.ajp.161.8.1488 · DOI · Paper page
- 10.1016/S0033-3182(09)70849-7 · doi:10.1016/s0033-3182(09)70849-7
- 10.1016/S0167-5699(99)01512-1 · DOI · Paper page
- 10.1002/art.23399 · DOI · Paper page
- 10.1097/PSY.0b013e31803174c0 · doi:10.1097/psy.0b013e31803174c0
- 10.1136/jnnp.2006.100644 · DOI · Paper page
- Bellone M, 2005, Autoimmune disease: pathogenesis
- 10.1016/j.it.2009.09.007 · DOI · Paper page
- 10.1186/1745-0179-3-31 · doi:10.1186/1745-0179-3-31
- 10.1176/jnp.15.2.145 · doi:10.1176/jnp.15.2.145 · Paper page
- 10.1016/S0006-3223(02)01452-X · DOI
- 10.1016/j.bbi.2009.04.008 · DOI
- 10.1017/S1092852912000338 · DOI · Paper page
- 10.1186/1752-1947-4-337 · doi:10.1186/1752-1947-4-337
- 10.1001/archneur.63.2.197 · DOI · Paper page
- Chang CC, 2005, Journal of Medical Sciences, 25, 101
- 10.1111/j.1600-065X.2011.01076.x · DOI
- 10.1016/j.neulet.2012.10.060 · DOI
- 10.4088/JCP.v66n0814 · DOI · Paper page
- 10.1016/j.autrev.2005.04.012 · DOI
- 10.1016/S1474-4422(10)70253-2 · DOI · Paper page
- 10.1002/jnr.21585 · DOI · Paper page
- 10.1192/bjp.bp.111.104471 · DOI
- 10.1038/nm1101-1189 · DOI · Paper page
- 10.1111/j.1399-5618.2012.01028.x · DOI
- 10.1016/j.psyneuen.2012.08.005 · DOI
- 10.1016/j.bbi.2011.03.013 · DOI · Paper page
- 10.1523/JNEUROSCI.15-10-06377.1995 · DOI · Paper page
- 10.1038/tp.2012.34 · DOI · Paper page
- Fairweather D, 2007, Autoimmune disease: mechanisms
- 10.1586/14737175.7.7.789 · DOI · Paper page
- 10.1126/science.272.5258.50 · DOI · Paper page
- 10.1002/art.22451 · DOI · Paper page
- 10.1385/ENDO:21:2:153 · DOI
- 10.1016/j.atherosclerosis.2006.10.009 · DOI
- 10.4088/PCC.v09n0411f · DOI
- 10.1016/j.cell.2007.06.033 · DOI · Paper page
- 10.1111/j.1469-8749.2011.03934.x · doi:10.1111/j.1469-8749.2011.03934.x
- 10.1038/nri2550 · DOI · Paper page
- 10.1016/0006-3223(90)90019-X · DOI
- 10.1002/(SICI)1520-6394(1997)5:2<91::AID-DA5>3.0.CO;2-8 · DOI · Paper page
- Harel L, 2006, Journal of Rheumatology, 33, 1873
- 10.1038/sj.gene.6363908 · doi:10.1038/sj.gene.6363908
- 10.4236/nm.2012.33026 · DOI
- 10.1016/j.biopsych.2007.03.017 · DOI · Paper page
- 10.1053/berh.2001.0223 · DOI
- 10.1016/j.euroneuro.2006.10.005 · DOI
- 10.1016/S0197-0186(96)00078-2 · DOI
- Hughes GRV, 1998, Clinical and Experimental Rheumatology, 16, 250
- 10.1136/pgmj.73.866.834 · DOI
- 10.1016/j.nbd.2010.04.017 · DOI · Paper page
- 10.1371/journal.pone.0045994 · DOI
- 10.1186/ar1224 · DOI
- 10.1212/01.wnl.0000267320.48939.d0 · DOI · Paper page
- 10.1016/j.biopsych.2005.08.001 · DOI
- 10.1002/ana.23626 · DOI · Paper page
- 10.1016/j.pneurobio.2011.08.008 · DOI
- Kapczinski F, 2009, Bipolar Disorders, 11, 221, 10.1111/j.1399-5618.2008.00616.x · DOI
- 10.1093/qjmed/93.3.169 · DOI
- 10.1017/S1461145708009310 · DOI · Paper page
- 10.1016/j.nbd.2011.01.025 · DOI · Paper page
- 10.1038/sj.mp.4001959 · DOI
- 10.1016/S0006-3223(01)01217-3 · DOI · Paper page
- 10.2741/3247 · DOI
- 10.1016/j.neuron.2013.04.005 · DOI · Paper page
- 10.1038/mp.2009.39 · DOI · Paper page
- 10.1016/j.neulet.2009.09.044 · DOI
- 10.1016/j.genhosppsych.2011.05.019 · doi:10.1016/j.genhosppsych.2011.05.019
- 10.1016/j.mito.2013.01.003 · DOI · Paper page
- 10.1523/JNEUROSCI.2723-06.2006 · DOI · Paper page
- 10.1186/2047-9158-1-9 · DOI · Paper page
- 10.1111/acn.12013 · DOI
- 10.1016/j.biopsych.2008.07.026 · DOI · Paper page
- 10.1038/tp.2011.37 · DOI · Paper page
- 10.1016/S0165-1781(96)02915-0 · DOI · Paper page
- 10.1111/j.1600-0447.1994.tb01527.x · DOI · Paper page
- 10.1016/j.jad.2011.08.023 · DOI
- 10.1016/j.neubiorev.2009.10.012 · DOI · Paper page
- 10.1192/apt.bp.108.005785 · DOI
- 10.1345/aph.10172 · doi:10.1345/aph.10172 · Paper page
- 10.1038/sj.mp.4000811 · DOI · Paper page
- 10.1002/ana.20890 · DOI · Paper page
- 10.1016/j.brainres.2005.12.056 · DOI · Paper page
- 10.2165/00023210-200721100-00002 · DOI · Paper page
- Monov S, 2008, Hippokratia, 12, 103
- 10.1016/j.clim.2008.10.010 · DOI
- 10.1016/0167-5699(96)80606-2 · DOI · Paper page
- 10.1016/S0197-0186(98)00026-6 · DOI
- 10.1016/j.ncl.2009.09.004 · DOI · Paper page
- 10.1111/j.1399-5618.2005.00196.x · DOI
- 10.1136/fn.88.3.F209 · DOI · Paper page
- 10.1038/nrn752 · DOI · Paper page
- 10.1155/2010/268436 · DOI
- 10.1111/j.1468-1331.2004.00976.x · DOI · Paper page
- 10.1111/j.1399-5618.2007.00493.x · DOI · Paper page
- 10.1038/nri702 · DOI · Paper page
- 10.1016/j.jneuroim.2007.01.003 · DOI · Paper page
- 10.1016/j.biopsych.2004.07.003 · DOI
- 10.1001/archgenpsychiatry.2009.116 · DOI · Paper page
- 10.3899/jrheum.071010 · DOI
- Plotnikoff NP, 2007, Cytokines: stress and immunity
- 10.2174/157015911796557984 · DOI · Paper page
- 10.1016/j.ijpsycho.2008.03.010 · DOI
- 10.1007/s11940-011-0116-y · DOI
- 10.1189/jlb.0710432 · DOI · Paper page
- 10.4049/jimmunol.182.2.1192 · DOI · Paper page
- 10.2174/13894501113149990014 · DOI · Paper page
- 10.1155/2009/278531 · DOI · Paper page
- 10.3109/08820139.2012.685537 · DOI
- 10.1124/pr.109.002469 · DOI · Paper page
- 10.1016/j.neuro.2009.03.004 · DOI
- 10.1503/jpn.100080 · DOI · Paper page
- 10.1016/0924-9338(96)80459-7 · doi:10.1016/0924-9338(96)80459-7
- 10.1016/j.phrs.2013.04.004 · DOI · Paper page
- 10.1016/j.coi.2007.04.005 · DOI · Paper page
- 10.1016/j.autrev.2007.11.007 · DOI · Paper page
- 10.1006/smns.1994.1034 · DOI
- Tedla Y, 2011, Ethiopian Medical Journal, 49, 211
- 10.1016/j.biopsych.2003.10.015 · DOI
- 10.1016/j.biopsych.2006.08.041 · DOI
- 10.1002/hup.390 · DOI · Paper page
- 10.1155/2012/819467 · DOI · Paper page
- Wallace DJ, 2006, Dubois’ lupus erythematosus
- 10.1016/j.neuroscience.2005.02.037 · DOI · Paper page
- 10.1176/appi.ajp.2009.09040487 · doi:10.1176/appi.ajp.2009.09040487
- Yeh HM, 2007, Journal of Internal Medicine of Taiwan, 18, 283
- 10.1177/0961203306070990 · doi:10.1177/0961203306070990
- 10.1007/s00406-009-0002-8 · DOI · Paper page
- 10.1186/1742-2094-7-80 · DOI · Paper page
- 10.1182/blood-2008-05-078154 · DOI · Paper page
- 10.1186/alzrt24 · DOI · Paper page
Cited by
Finucane, H. K., Reshef, Y. A., Anttila, V., Slowikowski, K., Gusev, A., Byrnes, A., Gazal, S., Loh, P.-R., Lareau, C., Shoresh, N., et al. (2018) · Nature Genetics · doi:10.1038/s41588-018-0081-4 · Cited by 1,097
The role of inflammation and microglial activation in the pathophysiology of psychiatric disorders
Réus, G. Z., Fries, G. R., Stertz, L., Badawy, M., Passos, I. C., Barichello, T., Kapczinski, F., & Quevedo, J. (2015) · Neuroscience · doi:10.1016/j.neuroscience.2015.05.018 · Cited by 594
Najjar, S., Pearlman, D. M., Devinsky, O., Najjar, A., & Zagzag, D. (2013) · Journal of Neuroinflammation · doi:10.1186/1742-2094-10-142 · Cited by 248
Tylee, D. S., Sun, J., Hess, J. L., Tahir, M. A., Sharma, E., Malik, R., Worrall, B. B., Levine, A. J., Martinson, J. J., Nejentsev, S., et al. (2018) · American Journal of Medical Genetics Part B: Neuropsychiatric Genetics · doi:10.1002/ajmg.b.32652 · Cited by 219
Rizzo, L. B., Costa, L. G., Mansur, R. B., Swardfager, W., Belangero, S. I., Grassi-Oliveira, R., McIntyre, R. S., Bauer, M. E., & Brietzke, E. (2014) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2014.02.004 · Cited by 183
Metadata
- Authors
- Rege, S., & Hodgkinson, S. J.
- Venue
- Australian & New Zealand Journal of Psychiatry
- Publisher
- SAGE Publications
- Published
- 2013-08-01
- Volume
- 47
- Issue
- 12
- Pages
- 1136-1151
- ISSN
- 0004-8674 (ISSN-L)
- 1440-1614
- OpenAlex
- W1978797722
- Cited by
- 91
- References
- 46
- FWCI
- 6.59
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- journals.sagepub.com/page/policies/text-and-data-mining-license (tdm)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.